Pricing Log in Create free account

Werewolf Therapeutics, Inc. (HOWL) vs LeonaBio, Inc. (LONA)

Werewolf Therapeutics, Inc. and LeonaBio, Inc. are both Biotechnology companies. Werewolf Therapeutics, Inc. and LeonaBio, Inc. are of similar size ($49.8M and $48.5M). LeonaBio, Inc. has the higher net margin (0.00% vs −141.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Werewolf Therapeutics, Inc. leads on 6 and LeonaBio, Inc. on 6.

Valuation

Metric HOWL LONA Biotechnology median
P/E n/m n/m 8.50
P/S 1.95 n/m 9.71
P/B 2.92 3.67 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.94 n/m 9.21
Earnings yield (74.49%) (444.41%) (33.15%)
Free cash flow yield (62.73%) (50.22%) (25.50%)

Profitability

Metric HOWL LONA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (128.18%) 0.00% 0.00%
Net margin (141.94%) 0.00% 0.00%
Free cash flow margin (122.51%) 0.00% 0.00%
Return on equity (119.86%) (431.39%) (56.36%)
Return on assets (59.31%) (306.05%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HOWL LONA Biotechnology median
Revenue growth (TTM) (5.21%) — 6.02%
EPS growth (last fiscal year) 18.40% 1.98% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HOWL LONA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.91 7.01 4.72
Net debt to EBITDA 0.97 0.87 0.96

Dividend

Metric HOWL LONA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HOWL LONA Biotechnology median
Market cap 48.46m 49.84m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack